Ascendiant Capital Maintains Buy on Cingulate, Lowers Price Target to $60
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Ascendiant Capital analyst Edward Woo maintains Cingulate (NASDAQ:CING) with a Buy and lowers the price target from $75 to $60.
Ascendiant Capital analyst Edward Woo maintains Cingulate (NASDAQ:CING) with a Buy and lowers the price target from $75 to $60.